Skip to main content
SpringerLink
Log in

Treatment of Status Epilepticus in Children

  • Therapy In Practice
  • Published:
Paediatric Drugs Aims and scope Submit manuscript

Abstract

Status epilepticus (SE) is a condition characterised by frequent and prolonged epileptic seizures which frequently develop in the immature brain. Fever, metabolic disorders and subtherapeutic concentrations of antiepileptic drugs are the most common factors precipitating SE in children.

Progressive neuronal damage occurs if convulsive SE persists for more than 30 minutes, with neurological, epileptic and cognitive sequelae. Unfortunately, the immature brain is more predisposed to SE and its sequelae than the mature brain.

SE may be categorised as convulsive, nonconvulsive or neonatal according to its responsiveness to antiepileptic drugs. Regardless of category, the main objective in the treatment of SE is to abort the seizures and treat the inciting condition.

Treatment includes: (i) monitoring of hydration, electrolyte balance, and cardiocirculatory and pulmonary functions; and (ii) rapid intravenous administration of specific antiepileptic drugs.

Benzodiazepines (usually diazepam, lorazepam or midazolam) are the most effective agents for the initial treatment of convulsive and nonconvulsive SE. In particular, midazolam infusion is an effective and well tolerated therapeutic approach for the management of childhood SE, including refractory SE. Phenytoin remains an excellent agent because of its long duration of action, but it is not active in nonconvulsive SE. Fosphenytoin, a phenytoin prodrug, represents a significant advance in the treatment of children with convulsive SE. Intravenous phenytoin and intramuscular phenobarbital (phenobarbitone) are generally used in neonatal SE; other agents are rarely used.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. ILAE commission on classification and terminology of the international league against epilepsy. Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia 1989; 30: 389–99

    Article  Google Scholar 

  2. Bone RC. Treatment of convulsive status epilepticus: recommendations of the epilepsy foundation of America’s working group on status epilepticus. JAMA 1993; 270(7): 854–9

    Article  Google Scholar 

  3. Gastaut H. Classification of status epilepticus. In: Delgado-Escueta AV, Porter RJ, Wasterlain CG, editors. Status epilepticus: mechanisms of brain damage and treatment. New York (NY): Raven, 1982: 13–8

    Google Scholar 

  4. Pellock JM. Status epilepticus in children: update and review. J Child Neurol 1994; 9Suppl. 2: 2827–35

    Google Scholar 

  5. Aicardi J, Chevrie JJ. Convulsive status epilepticus in infants and children: a study of 239 cases. Epilepsia 1970; 11: 187–97

    Article  PubMed  CAS  Google Scholar 

  6. Hauser WA. Status epilepticus: epidemiologic considerations. Neurology 1990; 40 (5 Suppl. 2): 13–22

    Google Scholar 

  7. Aminoff MJ, Simon RP. Status epilepticus: causes, clinical features and consequences in 98 patients. Am J Med 1980; 69: 657–66

    Article  PubMed  CAS  Google Scholar 

  8. Yager JY, Cheang M, Seshia SS. Status epilepticus in children. Can J Neurol Sci 1988; 15: 402–5

    PubMed  CAS  Google Scholar 

  9. Phillips SA, Shanahan RJ. Etiology and mortality of status epilepticus in children: a recent update. Arch Neurol 1989; 46: 74–6

    Article  PubMed  CAS  Google Scholar 

  10. Lothman EW. The biochemical basis and pathophysiology of status epilepticus. Neurology 1990; 40 (5 Suppl. 2): 13–23

    PubMed  CAS  Google Scholar 

  11. Wasterlain CG, Fujikawa DG, Penix LR, et al. Pathophysiological mechanisms of brain damage from status epilepticus. Epilepsia 1993; 34Suppl. 1: S37–53

    Article  PubMed  Google Scholar 

  12. Moshé SL. Seizures in the developing brain. Neurology 1993; 43 (11 Suppl. 5): S3–7

    PubMed  Google Scholar 

  13. Fountain NB, Lothman EW. Pathophysiology of status epilepticus. J Clin Neurophysiol 1995; 12(4): 326–42

    PubMed  CAS  Google Scholar 

  14. Hauser WA. Status epilepticus: frequency, etiology and neurological sequelae. In: Delgado-Escueta AV, Wasterlain CG, Treiman DG, et al., editors. Status epilepticus (Advances in Neurology. Vol. 34). New York (NY): Raven Press, 1983: 3–14

    Google Scholar 

  15. Lothman EW, Bertram III EH. Epileptogenic effects of status epilepticus. Epilepsia 1993; 34Suppl. 1: S59–70

    Article  PubMed  Google Scholar 

  16. Wasterlain CG, Shirasaka Y. Seizures, brain damage and brain development. Brain Dev 1994; 16: 279–95

    Article  PubMed  CAS  Google Scholar 

  17. Lockman LA. Treatment of status epilepticus in children. Neurology 1990; 40 (5 Suppl. 2): 43–6

    PubMed  CAS  Google Scholar 

  18. Ramsay RE. Treatment of status epilepticus. Epilepsia 1993; 34Suppl. 1: S71–81

    Article  PubMed  Google Scholar 

  19. Matthes JWA, Wallace SJ. Convulsive status epilepticus in children treated for epilepsy: an assessment of management. Dev Med Child Neurol 1995; 37: 226–31

    Article  PubMed  CAS  Google Scholar 

  20. Haafiz A, Kissoon N. Status epilepticus: current concepts. Pediatr Emerg Care 1999; 15(2): 119–29

    Article  PubMed  CAS  Google Scholar 

  21. McDonald RE, McLean MJ. Anticonvulsant drugs: mechanisms of action. In: Delgado-Escueta AV, Ward Jr AA, Woodbury DM, et al., editors. Basic mechanisms of the epilepsies: molecular and cellular approaches (Advances in Neurology. Vol. 44). New York (NY): Raven Press, 1986; 115–25

    Google Scholar 

  22. Shaner DM, McCurdy SA, Herring MO, et al. Treatment of status epilepticus: a prospective comparison of diazepam and phenytoin versus phenobarbital and optional phenytoin. Neurology 1988; 38: 202–7

    Article  PubMed  CAS  Google Scholar 

  23. Browne TR. The pharmacokinetics of agents used to treat status epilepticus. Neurology 1990; 40 (5 Suppl. 2): 28–31

    PubMed  CAS  Google Scholar 

  24. Magnussen I, Oxlund HRW, Alsbirk KE, et al. Absorption of diazepam in man following rectal and parenteral administration. Acta Pharmacol Toxicol 1979; 45: 88–90

    Google Scholar 

  25. Albano A, Reisdorff EJ, Wiegenstein JP. Rectal diazepam in pediatric status epilepticus. Am J Emerg Med 1988; 70: 168–72

    Google Scholar 

  26. Graves NM, Kriel RL. Rectal administration of antiepileptic drugs in children. Pediatr Neurol 1987; 3: 321–6

    Article  PubMed  CAS  Google Scholar 

  27. Treiman DM. The role of benzodiazepines in the management of status epilepticus. Neurology 1990; 40 (5 Suppl. 2): 32–42

    PubMed  CAS  Google Scholar 

  28. Scott RC, Neville BGR. Pharmacological management of convulsive status epilepticus in children. Dev Med Child Neurol 1999; 41: 207–10

    Article  PubMed  CAS  Google Scholar 

  29. Lal Koul R, Aithale G, Chacko A, et al. Continuous midazolam infusion as treatment of status epilepticus. Arch Dis Child 1997; 76(5): 445–8

    Article  Google Scholar 

  30. Kondall JL, Reynolds M, Goldberg R. Intranasal midazolam in patients with status epilepticus. Ann Emerg Med 1997; 29(3): 415–7

    Article  Google Scholar 

  31. Crawford TO, Mitchell WG, Fishman LS, et al. Very high dose phenobarbital for refractory status epilepticus in children. Neurology 1988; 38: 1035–40

    Article  PubMed  CAS  Google Scholar 

  32. Cranford RE, Leppik IE, Patrick B, et al. Intravenous phenytoin in acute treatment of seizures. Neurology 1979; 29: 1474–9

    Article  PubMed  CAS  Google Scholar 

  33. Pellock JM. Fosphenytoin use in children. Neurology 1996; 46 (6 Suppl. 1): S14–6

    Article  PubMed  CAS  Google Scholar 

  34. Czapinski P, Terczynoski A. Intravenous valproic acid administration in status epilepticus. Neurol Neurochir Pol 1998; 32(1): 11–22

    PubMed  CAS  Google Scholar 

  35. Snead III OC, Miles MV. Treatment of status epilepticus in children with rectal sodium valproate. J Pediatr 1985; 106: 323–5

    Article  PubMed  Google Scholar 

  36. Browne TR. Paraldehyde, chlormethozale and lidocaine for treatment of status epilepticus. Adv Neurol 1983; 34: 509–15

    PubMed  CAS  Google Scholar 

  37. Curless R, Holtzman B, Ramsay RE. Paraldehyde therapy in childhood status epilepticus. Arch Neurol 1983; 40: 477–80

    Article  PubMed  CAS  Google Scholar 

  38. Eriksson KL, Koivikko MJ. Status epilepticus in children: aetiology, treatment and outcome. Dev Med Child Neurol 1997; 39: 652–8

    Article  PubMed  CAS  Google Scholar 

  39. Borgeat A. Propofol: pro- or anticonvulsant?. Eur J Suppl Anaesthesiol 1997; 15: 17–22

    Article  CAS  Google Scholar 

  40. Cascino G. Non convulsive status epilepticus in adults and children. Epilepsia 1993; 34Suppl. 1: S21–8

    Article  PubMed  Google Scholar 

  41. De Negri M, Baglietto MG, Battaglia FM, et al. Treatment of electrical status epilepticus by short diazepam (DZP) cycles after DZP rectal bolus test. Brain Dev 1995; 17: 330–3

    Article  PubMed  Google Scholar 

  42. De Negri M. Electrical status epilepticus in childhood: neuropsychological impairment and therapeutic management. Dev Med Child Neurol 1994; 36: 192–5

    Google Scholar 

  43. De Negri M. Electrical status epilepticus during sleep (ESE): different clinical syndromes: towards a unifying view? Brain Dev 1997; 19: 447–51

    Article  PubMed  Google Scholar 

  44. Patry S, Lyagoubi S, Tassinari CA. Subclinical electrical status epilepticus induced by sleep in children. Arch Neurol 1971; 24: 242–52

    Article  PubMed  CAS  Google Scholar 

  45. Landau WM, Kleffner FR. Syndrome of acquired aphasia with convulsive disorder in children. Neurology 1957; 7: 523–30

    Article  PubMed  CAS  Google Scholar 

  46. Beaussart M. Benign epilepsy of children with rolandic (centropiramidal) paroxysmal foci. Epilepsia 1972; 14: 342–5

    Google Scholar 

  47. Kaplan PW. Intravenous valproate treatment of generalized nonconvulsive status epilepticus. Clin Electroencephalogr 1999; 30(1): 1–4

    PubMed  CAS  Google Scholar 

  48. Dreyfus-Brisac C, Monod N. Neonatal status epilepticus. In: Rémond A, editor. Neonatal status epilepticus. Vol. 15, Part B. Amsterdam: Elsevier, 1977: 39–52

    Google Scholar 

  49. Cukier F, Sfaello L, Dreyfus-Brisac C. Les états de mal du nouveau né dans un centre de réanimation néonatale. Gaslini 1976; 8: 100–6

    Google Scholar 

  50. Gilly R, Revol M, Dutruye J. et al. Convulsions et états de mal du nouveau-né. Lyon Med 1973; 229: 357–66

    Google Scholar 

  51. Lombroso CT. Differentiation of seizures in newborn and early infancy. In: Morselli PL, Pippenger CE, Penry JK, editors. Antiepileptic drug therapy in pediatrics. New York (NY): Raven Press, 1983; 85–102

    Google Scholar 

  52. Treiman DM. Electroclinical features of status epilepticus. J Clin Neurophysiol 1995; 12(4): 343–62

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Dipartimento di Scienze Neurologiche e della Visione, Sezione di Neuroscienze dello Sviluppo, Istituto G. Gaslini, Università di Genova, Largo G. Gaslini, 5, 16148, Genova, Italy

    Maurizio De Negri &  Maria Giuseppina Baglietto

Authors
  1. Maurizio De Negri
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Maria Giuseppina Baglietto
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Maria Giuseppina Baglietto.

Rights and permissions

Reprints and permissions

About this article

Cite this article

De Negri, M., Baglietto, M.G. Treatment of Status Epilepticus in Children. Paediatr Drugs 3, 411–420 (2001). https://doi.org/10.2165/00128072-200103060-00002

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128072-200103060-00002

Keywords

Search

Navigation